NRNP 6552 Week 8 Assignment
Common Health Conditions with Implications for Women
Subjective Data
Data Provided
The patient is a 48‑year‑old Asian American woman who presents with concerns about “thin bones,” motivated by her mother’s osteoporosis diagnosis at age 50 and subsequent hip fracture at 68 that required prolonged rehabilitation. She reports no personal history of fractures but expresses anxiety about her risk, particularly given her early menopause at 43–44 and hypothyroidism diagnosed at 40. She smokes one pack per day and has done so for 20 years, denies alcohol use, and describes a sedentary lifestyle associated with her work as an administrative assistant. Her past medical history includes melanoma removal in 2018 and two childbirths without complications. She currently lacks health insurance, and her husband has been unemployed for 9 months, creating financial strain that limits her access to preventive care. Family history is significant for maternal osteoporosis and hypertension, paternal hypertension, and cardiovascular disease in grandparents. Additional subjective data needed include her calcium and vitamin D intake, supplement use, caffeine consumption, exercise habits, fall history, thyroid medication adherence, reproductive history, and psychosocial barriers such as health literacy, transportation, and readiness to stop smoking.
Objective Data
Data Provided
The patient has a height of 5’2” and weight of 105 pounds, producing a BMI of 19.2, which is considered low and a risk factor for reduced bone density. Vital signs are stable with blood pressure 128/78 mmHg and heart rate 72/min. Physical examination reveals no abnormalities in HEENT, neck, lungs, cardiovascular, or abdomen. Breast exam shows fibrocystic changes without masses or discharge. Musculoskeletal exam demonstrates full range of motion in spine and shoulders without tenderness or spasms. The most significant finding is a DEXA T‑score of ‑1.2, consistent with osteopenia.
Diagnostic Tests, Procedures, and Laboratory Work
| Test | Rationale | Evidence |
| DEXA scan | Gold standard for measuring bone mineral density and monitoring progression from osteopenia to osteoporosis. | Eirini et al. (2022) highlight DXA as the diagnostic standard. |
| FRAX tool | Estimates 10‑year probability of hip and major osteoporotic fractures using bone density and clinical risk factors. | Widely recommended in fracture risk assessment guidelines. |
| Vertebral fracture assessment | Detects occult vertebral compression fractures that may be asymptomatic but increase future fracture risk. | James & Meertens (2025) emphasize its role in early detection. |
| Serum calcium, phosphorus, 25‑hydroxyvitamin D | Identifies nutritional deficiencies contributing to impaired bone mineralization. | Bartl (2023) notes vitamin D deficiency as a cause of osteomalacia. |
| Thyroid function tests (TSH, free T4) | Confirms appropriate hypothyroidism management and avoids overtreatment that accelerates bone loss. | Ambikairajah et al. (2022) link thyroid imbalance to bone metabolism. |
| Renal and liver function studies | Ensures safe initiation of long‑term pharmacologic therapy and rules out secondary contributors. | Standard baseline labs in osteoporosis management. |
| Complete blood count and metabolic panel | Provides baseline systemic health information before treatment initiation. | Recommended in comprehensive osteoporosis evaluation. |
Differential Diagnoses
Osteopenia
The patient’s DEXA scan shows a T‑score of ‑1.2, which falls within the diagnostic range for osteopenia. Risk factors include early menopause, low BMI, smoking history, and maternal osteoporosis. She has no prior fragility fractures, and her musculoskeletal exam is normal, making osteopenia the most consistent diagnosis. Early identification is critical to prevent progression.
Reference: Mun et al. (2025) emphasize that timely lifestyle modifications and monitoring in osteopenia reduce future fracture risk.
Osteoporosis
Although her T‑score does not meet the threshold of ‑2.5, her strong family history, early menopause, smoking, and low body weight place her at high risk for progression. Osteoporosis often remains silent until a fracture occurs, so surveillance is essential.
Reference: Yu et al. (2022) highlight that women with multiple risk factors are more likely to develop osteoporosis despite borderline bone density results.
Osteomalacia
Impaired bone mineralization due to vitamin D deficiency or inadequate calcium intake could mimic osteopenia. Her smoking history, low BMI, and financial strain may contribute to poor nutrition. Laboratory evaluation is needed to distinguish osteomalacia from osteoporosis.
Reference: Cianferotti (2022) notes that osteomalacia can present subtly, resembling osteopenia on bone density testing, but requires different treatment focused on correcting nutritional deficiencies.
Interventions for each Differential Diagnosis
Osteopenia
- Lifestyle modifications: Adequate calcium and vitamin D intake through diet or supplementation, smoking cessation, and regular weight‑bearing/resistance exercise.
- Fall prevention: Home safety modifications, balance training, and routine monitoring of bone density.
- Rationale: These strategies preserve skeletal health, delay progression to osteoporosis, and reduce fracture risk.
- Evidence: Reid & McClung (2024) emphasize osteopenia as a key target for fracture prevention through lifestyle measures.
Osteoporosis (if progression occurs)
- Pharmacologic therapy: Oral bisphosphonates (e.g., alendronate) as first‑line agents; alternatives include denosumab or intravenous zoledronic acid for intolerance.
- Adjunctive therapy: Selective estrogen receptor modulators (SERMs) for postmenopausal women.
- Continued supplementation: Calcium and vitamin D to maximize therapeutic benefit.
- Rationale: These medications inhibit bone resorption, improve bone density, and reduce vertebral and hip fracture risk.
- Evidence: Patel et al. (2023) highlight bisphosphonates as the cornerstone of osteoporosis management.
Osteomalacia
- Nutritional correction: Vitamin D supplementation and adequate calcium intake to restore normal bone mineralization.
- Counseling: Dietary guidance to address deficiencies, especially under financial constraints.
- Monitoring: Regular labs to evaluate vitamin D, calcium, phosphate, and parathyroid hormone levels.
- Rationale: Treatment focuses on correcting underlying deficiencies to improve bone strength and prevent recurrence.
- Evidence: Bartl (2023) underscores the importance of vitamin D and calcium replacement in osteomalacia management.
Social Determinants of Health (SDoH)
| SDoH Factor | Impact | Rationale |
| Financial strain (husband unemployed, no insurance) | Limits access to preventive care, diagnostic testing, and medications. | Nickles & Berkowitz (2025) note financial barriers delay routine care and reduce adherence to lifestyle changes. |
| Cultural background (Asian American woman) | Higher prevalence of low bone mineral density, increasing the risk of osteoporosis. | Lo et al. (2023) report Asian American women are at greater risk for osteoporosis compared to other groups. |
| Sedentary occupation (administrative assistant) | Reduces opportunities for weight‑bearing exercise, worsening bone health. | Physical inactivity is a modifiable risk factor for osteoporosis progression. |
| Smoking history (20 years, 1 pack/day) | Accelerates bone resorption and reduces calcium absorption, worsening bone density. | Zoulakis et al. (2026) highlight smoking as a major contributor to fracture risk in women. |
Collaborative Care Referrals & Patient Education
Endocrinology: Referral to endocrinology is appropriate for management of hypothyroidism and evaluation of bone health. Endocrinologists can optimize thyroid hormone therapy, which is essential because overtreatment or undertreatment can worsen bone loss (Ambikairajah et al., 2022).
Nutritionist/Dietitian: A nutritionist can provide counseling on adequate intake of calcium and vitamin D, balanced diet planning, and strategies to address nutritional gaps resulting from financial strain. Dietary guidance is critical in preventing progression from osteopenia to osteoporosis (Bartl, 2023).
Physical Therapy: Supports weight‑bearing and resistance exercise programs tailored to her low BMI and sedentary occupation. Structured exercise improves bone density and reduces fall risk (Reid & McClung, 2024).
Smoking Cessation Program: Given her 20‑year smoking history, referral to cessation resources is essential. Smoking accelerates bone resorption and increases fracture risk (Zoulakis et al., 2026).
Social Work Services: A social worker can assist with navigating financial barriers, identifying community resources, and exploring insurance or subsidy options. Addressing these barriers improves adherence to preventive care (Nickles & Berkowitz, 2025).
Patient Education
Calcium and Vitamin D Intake: Encourage daily intake through diet or supplements to support bone mineralization and prevent progression of osteopenia.
Weight‑Bearing Exercise: Promote walking, resistance training, or yoga to strengthen bones and improve balance.
Smoking Cessation: Educate on the impact of smoking on bone health and provide strategies for quitting.
Fall Prevention: Teach home safety modifications, balance training, and regular vision checks to reduce fracture risk.
Bone Density Monitoring: Explain the importance of routine DEXA scans for tracking changes and guiding timely interventions.
References
Ambikairajah, A., Walsh, E., & Cherbuin, N. (2022). A review of menopause nomenclature. Reproductive Health, 19(1), 29. https://doi.org/10.1186/s12978-022-01336-7
Bartl, R. (2023). Calcium and Vitamin D deficiency and osteomalacia. In Osteoporosis in Clinical Practice (pp. 77–90). Cham: Springer International Publishing. https://doi.org/10.1007/978-3-031-14652-7_8
Cianferotti, L. (2022). Osteomalacia is not a single disease. International Journal of Molecular Sciences, 23(23), 14896. https://doi.org/10.3390/ijms232314896
Eirini, K., Nikolaos, T., Papadopoulou, S. K., & Georgios, G. (2022). Bone density measurements and biomarkers in nutrition: DXA (Dual-energy X-ray Absorptiometry), osteopenia, and osteoporosis. In Biomarkers in Nutrition (pp. 1067–1084). Cham: Springer International Publishing. https://doi.org/10.1007/978-3-031-07389-2_63
James, R., & Meertens, R. (2025). A retrospective service evaluation of patient awareness and engagement, and medication compliance and adherence, in patients with opportunistically identified vertebral fragility fractures in a local fracture liaison service. Radiography, 31(1), 406–414. https://doi.org/10.1016/j.radi.2024.12.019
Lo, J. C., Yang, W., Park-Sigal, J. J., & Ott, S. M. (2023). Osteoporosis and fracture risk among older US Asian adults. Current Osteoporosis Reports, 21(5), 592-608. https://doi.org/10.1007/s11914-023-00805-7
Mun, J., Kim, M., Song, J., Chung, Y., Park, J., & Park, J. (2025). Individualized fracture prevention for postmenopausal women with osteopenia. Journal of Menopausal Medicine, 31(3), https://doi.org/10.6118/jmm.25148
Nickles, S., & Berkowitz, S. (2025). Impact of social determinants of health on the implementation of lifestyle medicine. In Lifestyle Medicine: Closing Research, Practice, and Knowledge Gaps (pp. 703–717). Cham: Springer Nature Switzerland. https://doi.org/10.1007/978-3-031-82888-1_35
Patel, D., Gorrell, C., Norris, J., & Liu, J. (2023). A narrative review of the pharmaceutical management of osteoporosis. Annals of Joint, 8, 25. https://doi.org/10.21037/aoj-23-2
Reid, I. R., & McClung, M. R. (2024). Osteopenia: a key target for fracture prevention. The Lancet Diabetes & Endocrinology, 12(11), 856–864. https://doi.org/10.1016/S2213-8587(24)00225-0
Yu, Z., Wu, Y., Zhang, R., Li, Y., Zang, S., & Liu, J. (2022). Increased risk of non-alcoholic fatty liver disease fibrosis is closely associated with osteoporosis in women but not in men with type 2 diabetes. Endocrine Connections, 11(11). https://doi.org/10.1530/EC-22-0174
Zoulakis, M., Ambjörn, M., Jaiswal, R., Axelsson, K. F., Litsne, H., Johansson, L., & Lorentzon, M. (2026). Impact of current and previous smoking on fracture risk in older women: the role of physical function, bone density, and bone microarchitecture. Journal of Bone and Mineral Research, zjag028. https://doi.org/10.1093/jbmr/zjag028
CLICK HERE TO ORDER A PLAGIARISM-FREE PAPER
Case 2
A 48-year-old Asian American woman is concerned about thin bones. Her mother was diagnosed with osteoporosis at the age of 50 and fell at the age of 68 and fractured her hip and spent months in Rehab before being able to return home. The patient has no history of fractures.
The patient presents to the office to have her bones checked to see if she has “thin bones”
Patient has no history of previous fractures: Patient states she went through Menopause at the
age of 43-44 with no major problems. Patient was diagnosed with hypothyroid at at age 40.
Patient does not drink. Smokes 1ppd for 20 yrs. Husband has been out of work for 9 months due to downsizing at his job. Pt works as an administrative assistant for a publisher but does not have health insurance at this time.Pt had a melanoma removed from her left cheek in 2018; No hospitalizations except for childbirth x2.
Family history: Paternal Grandmother died at age 78 due to heart disease. Paternal Grandfather
died at age 83 due to heart attack. Maternal Grandmother died at age 82 cause unknown;
Maternal Grandfather died from farm accident at age of 56. Mother is 75 alive with Osteoporosis
diagnosed at age 50 and HTN diagnosed at age 63. Father is 77 alive with HTN diagnosed at age45. Pt has two daughters alive and well with no medical problems.
Objective Info
Height 5’2’ Wt 105 lbs; BMI 19.2; 128/78; HR-72/min
• HEENT: Normocephalic, no lumps/lesions
• Neck: supple without adenopathy , no thyromegaly.
• Lungs: Eupneic, CTA
• CV: RRR, no murmurs, rubs or extra sounds noted; 2+ peripheral pulses, no edema noted
• Breast: soft, fibrocystic changes bilaterally, without masses, dimpling or discharge
• Abd: soft, +BS, no tenderness
• MS: Full ROM in spine and shoulders. No tenderness, no spasms
• T-Score is -1.2
- Use the Case Study Template from the Learning Resources to complete the assignment. Your submission must include a brief case write-up, followed by the fully completed template, which must be integrated into the document rather than submitted separately.
- Include a title page, a case summary in your own words, the completed template, and a reference page formatted in APA style.
- Ensure your submission meets all criteria outlined in the template and rubric for completeness and accuracy.